Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

This publication has 96 references indexed in Scilit:

• Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty
  American Heart Journal, 1992
• Fish oil supplements for prevention of restenosis after coronary angioplasty
  International Journal of Cardiology, 1992
• Direct intraarterial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty
  American Heart Journal, 1991
• Effects of diltiazem on complications and restenosis after coronary angioplasty
  The American Journal of Cardiology, 1991
• Atherosclerotic Yucatan microswine: An animalmodel with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions
  American Heart Journal, 1990
• Platelets and Thrombolytic Therapy
  New England Journal of Medicine, 1990
• Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
  American Heart Journal, 1989
• Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment
  The American Journal of Cardiology, 1989
• Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1989
• Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids
  New England Journal of Medicine, 1988